Gonadotropin-releasing hormone (GnRH)-agonist versus GnRH-antagonist in ovarian stimulation for assisted reproductive techniques: Results of a prospective randomized trial

被引：3
|
作者：
Freitas, GC
Cavagna, M
Dzik, A
Soares, JB
Szterenfeld, C
Izzo, VM
机构：
[1] Womens Hlth Reference Ctr, Sao Paulo, Brazil
[2] Univ Santo Amaro, Sch Med, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
来源：
FERTILITY AND STERILITY | 2004年 / 82卷
关键词：
D O I：
10.1016/j.fertnstert.2004.07.613
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P271
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [41] ELAGOLIX SODIUM Gonadotropin-Releasing Hormone (GnRH) Antagonist Treatment of Endometriosis
    Peng, X. V.
    DRUGS OF THE FUTURE, 2013, 38 (04) : 221 - 226
  • [42] Gonadotropin releasing hormone (GnRH) antagonist (cetrorelix) versus GnRH agonist treatment - an age and gonadotropin matched study in young normal responders
    Berger, BM
    Ezcurra, D
    Alper, MM
    FERTILITY AND STERILITY, 2004, 82 : S235 - S236
  • [43] Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response
    De Placido, G
    Mollo, A
    Clarizia, R
    Strina, I
    Conforti, S
    Alviggi, C
    FERTILITY AND STERILITY, 2006, 85 (01) : 247 - 250
  • [44] Microdose Flare-Up Gonadotropin-Releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols for Poor Responder Patients: A Meta-Analysis
    De Pinho, Joao
    Gibbons, Willam
    Kovanci, Ertug
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 115A - 115A
  • [45] Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol
    Orvieto, Raoul
    Volodarsky, Michael
    Hod, Eduard
    Homburg, Roy
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Meltcer, Simion
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (08) : 494 - 496
  • [46] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Griesinger, Georg
    Mochtar, Monique H.
    Aboulfoutouh, Ismail
    Khattab, Sherif M.
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [47] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Ginevra Mills
    Michael H. Dahan
    Archives of Gynecology and Obstetrics, 2022, 306 : 1731 - 1737
  • [48] INDUCTION OF REPRODUCTIVE ACTIVITY IN LACTATING EWES WITH GONADOTROPIN-RELEASING HORMONE (GNRH)
    RESTALL, BJ
    RADFORD, HM
    JOURNAL OF REPRODUCTION AND FERTILITY, 1974, 36 (02): : 475 - 476
  • [49] Presence of gonadotropin-releasing hormone (GnRH) mRNA in Rathke's pouch and effect of the GnRH-antagonist ORG30276 on lactotroph development in vitro
    Van Bael, A
    Seuntjens, E
    Proesmans, M
    Denef, C
    JOURNAL OF NEUROENDOCRINOLOGY, 1998, 10 (06) : 437 - 445
  • [50] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Mochtar, Monique H.
    Griesinger, Georg
    Mohesen, Mohamed Nagi
    Aboulfoutouh, Ismail
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
12345